Menu

ImmunityBio, Inc. IBRX

Full chart Compare
Set alert

Price alert · IBRX

All alert types
6.07 USD -0.60 (-9.00%)

At closeNov 13, 2026, 4:00 AM EST

6.10 +0.03 +0.49%

Pre-market · Nov 13, 4:00 AM ET

6.00 Day range 6.50
1.95 52-week range 12.43
YTD
+206.57%
1 year
+194.66%

Discussion (3508)

Sign in to join the discussion

frank fager IBRX 9 months ago #2081

Jim Cramer is a bought and paid for puppet working for MSM big Pharma and Wall Street total POS scumbag

Remember during Covid he was jab jab jab really and what's your experience. Harvard law not med school. He has a no science background zero

frank fager IBRX 9 months ago #2082

Nick you nailed it. Pomerancz

"Pomerantz LLP, founded over 85 years ago and recognized as a premier firm for securities class actions"

Parasites these law firms are dens of parasitic scum with no morals. Scum of the earth. They are exactly what gives attorneys a bad reputation and generates wide spread hate towards all attorneys.

frank fager IBRX 9 months ago #2083

The wide spread use in Saudi will finally show the true potential of Anktiva.... Why? Because it will be first line used before the patients immune systems were severely weakened by chemo and radiation. It will truly shine.

frank fager IBRX 9 months ago #2084

Paul Silberberg

Wow wow wow first good
Posts ever on this board

frank fager IBRX 9 months ago #2085

I think IBRX may show a profit in 4th quarter 2026

frank fager IBRX 9 months ago #2086

I think tomorrow will be similar

Next week maybe get a green week
Let's hope and build momentum heading to March 3-2

Should see a run in February into earnings

frank fager IBRX 9 months ago #2087

I have 420,000x$100=$42 million
Buying a used Brinks truck to pick up the cash :)

frank fager IBRX 9 months ago #2088

Not a lawsuit an investigation INVESTIGATION get a negative news event to help shorts

frank fager IBRX 9 months ago #2089

Not being sued it's a paid news release is my bet by the shorts and or big pharma...

"ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ImmunityBio, Inc. - IBRX
Pomerantz LLP"

That's a classic short cover move create negative news true or false doesn't matter it's by design.

frank fager IBRX 9 months ago #2090

ImmunityBio will be profitable late 2026 and starting next year every year going forward with hyper sales growth and profit growth